Literature DB >> 11799157

Nef-mediated resistance of human immunodeficiency virus type 1 to antiviral cytotoxic T lymphocytes.

Otto O Yang1, Phuong Thi Nguyen, Spyros A Kalams, Tanya Dorfman, Heinrich G Göttlinger, Sheila Stewart, Irvin S Y Chen, Steven Threlkeld, Bruce D Walker.   

Abstract

Although Nef has been proposed to effect the escape of human immunodeficiency virus type 1 (HIV-1) from cytotoxic T lymphocytes (CTL) through downmodulation of major histocompatibility complex class I molecules, little direct data have been presented previously to support this hypothesis. By comparing nef-competent and nef-deleted HIV-1 strains in an in vitro coculture system, we demonstrate that the presence of this viral accessory gene leads to impairment of the ability of HIV-1-specific CTL clones to suppress viral replication. Furthermore, inhibition by genetically modified CTL that do not require major histocompatibility complex class I-presented antigen (expressing the CD4 T-cell receptor [TCR] zeta-chain hybrid receptor) is similar for both nef-competent and -deleted strains, indicating that Nef does not impair the effector functions of CTL but acts at the level of TCR triggering. In contrast, we note that another accessory gene, vpr, does not induce resistance of HIV-1 to suppression by CTL clones. We conclude that Nef (and not Vpr) contributes to functional HIV-1 immune evasion and that this effect is mediated by diminished antigen presentation to CTL.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11799157      PMCID: PMC135916          DOI: 10.1128/jvi.76.4.1626-1631.2002

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  65 in total

1.  Lysis of HIV-1-infected cells and inhibition of viral replication by universal receptor T cells.

Authors:  O O Yang; A C Tran; S A Kalams; R P Johnson; M R Roberts; B D Walker
Journal:  Proc Natl Acad Sci U S A       Date:  1997-10-14       Impact factor: 11.205

Review 2.  Regulation of HIV gene expression.

Authors:  B R Cullen
Journal:  AIDS       Date:  1995       Impact factor: 4.177

Review 3.  CD8+ cells in human immunodeficiency virus type I pathogenesis: cytolytic and noncytolytic inhibition of viral replication.

Authors:  O O Yang; B D Walker
Journal:  Adv Immunol       Date:  1997       Impact factor: 3.543

Review 4.  Antigen-specific T-cell receptors and their reactions with complexes formed by peptides with major histocompatibility complex proteins.

Authors:  H N Eisen; Y Sykulev; T J Tsomides
Journal:  Adv Protein Chem       Date:  1996

5.  Strong cytotoxic T cell and weak neutralizing antibody responses in a subset of persons with stable nonprogressing HIV type 1 infection.

Authors:  T Harrer; E Harrer; S A Kalams; T Elbeik; S I Staprans; M B Feinberg; Y Cao; D D Ho; T Yilma; A M Caliendo; R P Johnson; S P Buchbinder; B D Walker
Journal:  AIDS Res Hum Retroviruses       Date:  1996-05-01       Impact factor: 2.205

6.  Suppression of human immunodeficiency virus type 1 replication by CD8+ cells: evidence for HLA class I-restricted triggering of cytolytic and noncytolytic mechanisms.

Authors:  O O Yang; S A Kalams; A Trocha; H Cao; A Luster; R P Johnson; B D Walker
Journal:  J Virol       Date:  1997-04       Impact factor: 5.103

7.  Conservation and host specificity of Vpr-mediated cell cycle arrest suggest a fundamental role in primate lentivirus evolution and biology.

Authors:  G L Stivahtis; M A Soares; M A Vodicka; B H Hahn; M Emerman
Journal:  J Virol       Date:  1997-06       Impact factor: 5.103

8.  The human immunodeficiency virus type 1 capsid p2 domain confers sensitivity to the cyclophilin-binding drug SDZ NIM 811.

Authors:  T Dorfman; H G Göttlinger
Journal:  J Virol       Date:  1996-09       Impact factor: 5.103

9.  Efficient lysis of human immunodeficiency virus type 1-infected cells by cytotoxic T lymphocytes.

Authors:  O O Yang; S A Kalams; M Rosenzweig; A Trocha; N Jones; M Koziel; B D Walker; R P Johnson
Journal:  J Virol       Date:  1996-09       Impact factor: 5.103

10.  The HIV nef protein associates with protein kinase C theta.

Authors:  B L Smith; B W Krushelnycky; D Mochly-Rosen; P Berg
Journal:  J Biol Chem       Date:  1996-07-12       Impact factor: 5.157

View more
  52 in total

1.  Recent Insights into HIV Accessory Proteins.

Authors:  Jenny L. Anderson; Thomas J. Hope
Journal:  Curr Infect Dis Rep       Date:  2003-10       Impact factor: 3.725

2.  Different in vivo effects of HIV-1 immunodominant epitope-specific cytotoxic T lymphocytes on selection of escape mutant viruses.

Authors:  Hirokazu Koizumi; Masao Hashimoto; Mamoru Fujiwara; Hayato Murakoshi; Takayuki Chikata; Mohamed Ali Borghan; Atsuko Hachiya; Yuka Kawashima; Hiroshi Takata; Takamasa Ueno; Shinichi Oka; Masafumi Takiguchi
Journal:  J Virol       Date:  2010-03-24       Impact factor: 5.103

3.  A noncanonical mu-1A-binding motif in the N terminus of HIV-1 Nef determines its ability to downregulate major histocompatibility complex class I in T lymphocytes.

Authors:  Sayuki Iijima; Young-Jung Lee; Hirotaka Ode; Stefan T Arold; Nobuyuki Kimura; Masaru Yokoyama; Hironori Sato; Yasuhito Tanaka; Klaus Strebel; Hirofumi Akari
Journal:  J Virol       Date:  2012-02-01       Impact factor: 5.103

4.  CD4 and MHC-I downregulation are conserved in primary HIV-1 Nef alleles from brain and lymphoid tissues, but Pak2 activation is highly variable.

Authors:  Kristin Agopian; Bangdong L Wei; J Victor Garcia; Dana Gabuzda
Journal:  Virology       Date:  2006-09-18       Impact factor: 3.616

Review 5.  HIV accessory proteins and surviving the host cell.

Authors:  Jenny L Anderson; Thomas J Hope
Journal:  Curr HIV/AIDS Rep       Date:  2004-04       Impact factor: 5.071

6.  Pol-specific CD8+ T cells recognize simian immunodeficiency virus-infected cells prior to Nef-mediated major histocompatibility complex class I downregulation.

Authors:  Jonah B Sacha; Chungwon Chung; Jason Reed; Anna K Jonas; Alexander T Bean; Sean P Spencer; Wonhee Lee; Lara Vojnov; Richard Rudersdorf; Thomas C Friedrich; Nancy A Wilson; Jeffrey D Lifson; David I Watkins
Journal:  J Virol       Date:  2007-08-15       Impact factor: 5.103

7.  Epitope targeting and viral inoculum are determinants of Nef-mediated immune evasion of HIV-1 from cytotoxic T lymphocytes.

Authors:  Diana Y Chen; Arumugam Balamurugan; Hwee L Ng; William G Cumberland; Otto O Yang
Journal:  Blood       Date:  2012-05-21       Impact factor: 22.113

8.  HIV-1 Nef responsiveness is determined by Env variable regions involved in trimer association and correlates with neutralization sensitivity.

Authors:  Yoshiko Usami; Heinrich Göttlinger
Journal:  Cell Rep       Date:  2013-10-24       Impact factor: 9.423

9.  Simultaneous assessment of CD4 and MHC-I downregulation by Nef primary isolates in the context of infection.

Authors:  Ayub Ali; Susan Realegeno; Otto O Yang; Martha J Lewis
Journal:  J Virol Methods       Date:  2009-07-28       Impact factor: 2.014

10.  Reactivation Kinetics of HIV-1 and Susceptibility of Reactivated Latently Infected CD4+ T Cells to HIV-1-Specific CD8+ T Cells.

Authors:  Victoria E K Walker-Sperling; Valerie J Cohen; Patrick M Tarwater; Joel N Blankson
Journal:  J Virol       Date:  2015-07-15       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.